冠狀動脈栓塞保護裝置的全球市場:規模，佔有率，COVID-19影響分析(2023年～2029年):MedCore

2022年全球冠狀動脈栓塞防護裝置市場規模將達8000萬美元。預計未來該市場將以 -1.4% 的複合年增長率下降，到 2029 年將達到 7300 萬美元。

本報告提供全球冠狀動脈栓塞保護裝置市場相關調查，提供市場概要，以及各市場區隔，各地區趨勢，競爭情形等資訊。

目錄

冠狀動脈栓塞保護裝置市場

• 摘要整理
  • 全球冠狀動脈栓塞保護裝置市場概要
  • 競爭分析
  • 對像地區
• 簡介
  • 保護機制
• 市場分析與預測
• 促進因素與阻礙因素
  • 市場促進因素
  • 市場阻礙因素
• 競爭市場佔有率分析

The global embolic protection device market is projected to experience a decline in market value over the forecast period. In 2022, the market was valued at $80 million, and by 2029, it is estimated to reach $73 million. This indicates a negative compound annual growth rate (CAGR) of -1.4%. The anticipated decrease in market value suggests potential challenges or factors impacting the demand and adoption of embolic protection devices during the forecast period.

GLOBAL CORONARY EMBOLIC PROTECTION DEVICE DATA INCLUDED:

• Unit Sales, Average Selling Prices, Market Size & Growth Trends
• Procedure Volumes
• Market Drivers & Limiters
• Market Forecasts Until 2027, and Historical Data to 2017
• Recent Mergers & Acquisitions
• Disease Overviews and Demographic Information
• Company Profiles, Product Portfolios, and SWOT for Top Competitors

PROCEDURE VOLUMES

Through our research on the global coronary embolic protection device market, iData Research has conducted a thorough analysis of procedure volumes related to angiography, angioplasty (or PCI), atherectomy, and catheterization. This meticulous examination allows us to enhance the accuracy of our market sizing and provide comprehensive procedure volume data spanning a 10-year range across 70 countries. By incorporating procedure volumes into our analysis, we aim to provide you with a comprehensive understanding of the market dynamics and trends related to coronary embolic protection devices.

GLOBAL CORONARY EMBOLIC PROTECTION DEVICE MARKET INSIGHTS

The use of embolic protection devices (EPDs) in interventional cardiology procedures has been limited due to the associated cost burden. This has resulted in physicians shifting away from utilizing EPDs, which in turn affects unit sales. EPDs are not deemed essential devices in interventional cardiology and may not always be covered under national reimbursement schedules. Consequently, the adoption of these devices is not expected to see significant growth, leading to a modest decline in the market.

MARKET SHARE INSIGHTS

The global coronary embolic protection device market was dominated by three key players: Boston Scientific, Medtronic, and Abbott. These companies held significant market share and played a crucial role in shaping the industry.

In 2022, Boston Scientific emerged as the leading competitor in the global coronary embolic protection device market. Their product offerings, such as the FilterWire EZ™ and SENTINEL™ Cerebral Protection System, contributed to their market dominance.

Medtronic held the second position in the coronary EPD market in 2022, with their Mo.Ma™ Ultra proximal cerebral protection device.

Abbott, as the third-leading competitor, offered the RX Accunet® embolic protection systems specifically designed for carotid interventions, featuring rapid exchange delivery.

These three companies played a significant role in driving innovation and competition within the coronary embolic protection device market.

RESEARCH REGIONAL COVERAGE

Throughout this research series, iData Research has covered over 70 countries across the globe in great detail. The regions covered include:

• North America (the United States and Canada),
• Latin America (Brazil, Mexico, Colombia, Argentina, Peru, Chile, Venezuela, and Other),
• Western Europe (Germany, France, Italy, Spain, Switzerland, Austria, Portugal, Benelux, Scandinavia, and Other),
• Central and Eastern Europe (Poland, Turkey, Russia, Greece, Czech Republic, Croatia, Bulgaria, Ukraine, Kazakhstan, Hungary, Romania, Baltic States (Estonia, Latvia, and Lithuania), and Other),
• Middle East (Saudi Arabia, UAE, Israel, Iran, Kuwait, Qatar, Bahrain, Oman, and Other),
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Indonesia, Malaysia, Thailand, the Philippines, Brunei, Myanmar, Cambodia, Vietnam, New Zealand, Taiwan, Hong Kong, and Other),
• Africa (South Africa, Egypt, Morocco, Ghana, Nigeria, Libya, Sudan, Uganda, Kenya, and Other)

Table of Contents

Coronary embolic protection device Market

• 10.1. Executive Summary
  • 10.1.1. Global Coronary Embolic Protection Device Market Overview
  • 10.1.2. Competitive Analysis
  • 10.1.3. Regions Included
• 10.2. Introduction
  • 10.2.1. Protection Mechanism
    • 10.2.1.1. Filter Basket
    • 10.2.1.2. Distal Balloon Occlusion
• 10.3. Market Analysis and Forecast
• 10.4. Drivers and Limiters
  • 10.4.1. Market Drivers
  • 10.4.2. Market Limiters
• 10.5. Competitive Market Share Analysis

LIST OF CHARTS

• Chart 10-1: Coronary Embolic Protection Device Market, Global, 2022 & 2029
• Chart 10-2: Coronary Embolic Protection Procedures, Global, 2022
• Chart 10-3: Leading Competitors, Coronary Embolic Protection Device Market, Global, 2022

LIST OF FIGURES

• Figure 10-1: Coronary Embolic Protection Device Regions Covered, Global (1 of 2)
• Figure 10-2: Coronary Embolic Protection Device Regions Covered, Global (2 of 2)
• Figure 10-3: Coronary Embolic Protection Device Market, Global, 2019 - 2029
• Figure 10-4: Units Sold by Region, Coronary Embolic Protection Device Market, Global, 2019 - 2029
• Figure 10-5: Average Selling Price by Region, Coronary Embolic Protection Device Market, Global, 2019 - 2029 (US$)
• Figure 10-6: Market Value by Region, Coronary Embolic Protection Device Market, Global, 2019 - 2029 (US$M)
• Figure 10-7: Leading Competitors, Coronary Embolic Protection Device Market, Global, 2022